Humanetics receives $3.8M government grant to protect patients from radiation
Congress has awarded pharmaceutical company, Humanetics, an additional $3.8 million from the fiscal year 2008 Defense Appropriations Act, signed by President Bush, to develop medical radiation countermeasures to protect patients against the harmful effects of ionizing radiation.
The award brings the total funding from the Department of Defense to just under $7 million, according to the Minneapolis-based Humanetics.
Humanetics said the 2008 funding will be used to continue development, clinical testing, regulatory approval, manufacturing and commercialization of a number of Medical Radiation Countermeasures. Its leading candidate, BIO 300, is currently undergoing large animal efficacy and human safety trials, according to the company.
The award brings the total funding from the Department of Defense to just under $7 million, according to the Minneapolis-based Humanetics.
Humanetics said the 2008 funding will be used to continue development, clinical testing, regulatory approval, manufacturing and commercialization of a number of Medical Radiation Countermeasures. Its leading candidate, BIO 300, is currently undergoing large animal efficacy and human safety trials, according to the company.